Product Information
OXYBUTYNIN 5 MG/5 ML SOLUTION is a generic product labeled by Chartwell RX LLC, priced at $0.0327 per ML under NDC 62135052047. Its NADAC has been published 179 times since May 3, 2023.
FDA first approved this application on Jan 29, 1999. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/5mL
Manufacturer
Chartwell RX LLCNDC
62135052047
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075039FDA Approved
1/29/1999
TE Code
AA
On Market Since
1/29/1999
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN 5 MG/5 ML SOLUTION has been published 179 times since May 3, 2023, and over the history we have for it it has risen 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0327 per ML |
|---|---|
| All-time high | $0.0350 (Sep 13, 2023) |
| All-time low | $0.0260 (Nov 20, 2024) |
| 52-week high | $0.0327 |
| 52-week low | $0.0317 |
| Median price | $0.0320 |
| Average price | $0.0311 |
| Largest weekly change | -23.1% (Nov 20, 2024) |
| Weeks tracked | 179 |
| Tracking since | May 3, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Oxybutynin Chloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oxybutynin Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN 5 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN 5 MG/5 ML SOLUTION, manufactured by Chartwell RX LLC, is $0.0327 per ML (NDC 62135052047), effective Sep 30, 2026.
How has the price of OXYBUTYNIN 5 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN 5 MG/5 ML SOLUTION has risen 4.8%. It has been tracked across 179 weekly CMS publications since May 3, 2023.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN 5 MG/5 ML SOLUTION?
Since May 3, 2023, the NADAC for OXYBUTYNIN 5 MG/5 ML SOLUTION has ranged from a low of $0.0260 (Nov 20, 2024) to a high of $0.0350 (Sep 13, 2023), with a median of $0.0320 per ML.
Are there cheaper alternatives to OXYBUTYNIN 5 MG/5 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of OXYBUTYNIN 5 MG/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OXYBUTYNIN 5 MG/5 ML SOLUTION?
OXYBUTYNIN 5 MG/5 ML SOLUTION (NDC 62135052047) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.